ArticlePharmacoEconomics - open2025

Cost Effectiveness of Recombinant Zoster Vaccine and Live-Attenuated Vaccine Against Herpes Zoster for Adults Aged 50 and Over in China.

Lulu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.